๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of assumed versus measured oxygen consumption for the determination of cardiac output using the Fick principle

โœ Scribed by Wolf, Andreas ;Pollman, Matthew J. ;Trindade, Pedro T. ;Fowler, Michael B. ;Alderman, Edwin L.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
176 KB
Volume
43
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

โœฆ Synopsis


Assumed oxygen consumption (VO 2 ) is increasingly used as a convenient surrogate for measured VO 2 for calculation of cardiac output. This substitution is often based on empirical formulae, previously validated only in relatively young patients. To assess the inaccuracy introduced by extrapolating these formulae to older patients, we compared measured VO 2 with assumed VO 2 in 57 patients. VO 2 was measured using an open circuit analyzer. Assumed VO 2 was calculated according to the LaFarge or Bergstra formulae. Agreement between both methods was assessed according to the method of Bland and Altman. The mean difference of measured VO 2 minus assumed VO 2 was 7.9 ml/min/m 2 (P F 0.02) using the LaFarge formula, and ุŠ15.6 ml/min/m 2 (P F 0.0002) using the Bergstra formula across a range of measured VO 2 from 70 to 176 ml/min/m 2 . A systematic error was introduced by assumed VO 2 from both formulae of underestimating higher and overestimating lower values of VO 2 , resulting in poor overall agreement with measured VO 2 . The same error and poor agreement was found when analyzing subgroups of patients H60 or F70 years of age.

In summary, use of assumed VO 2 introduces large, unpredictable errors in adult patients, suggesting requirement for measurement of VO 2 when calculating cardiac output.


๐Ÿ“œ SIMILAR VOLUMES


Use of bioimpedance for measuring cardia
โœ Michael J. DePasquale; Anthony A. Fossa ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 891 KB

Cardiovascular profiling of developmental compounds by General Pharmacology/ Safety Pharmacology is an integral part of the drug discovery process in support of registration of clinical candidates. Non-invasive screening tools which provide hemodynamic measurements can facilitate the drug developmen